All Work

Chris Lange

Pfizer Sinks Despite Winning FDA Approval

Pfizer has announced that the FDA approved Xeljanz XR (tofacitinib citrate) extended-release tablets for the once-daily treatment of moderate to severe rheumatoid arthritis in certain patients.

Chris Lange · 11 years ago

Avis Crumbles on Weak Guidance

Avis Budget Group released its fourth-quarter financial results after the markets closed on Tuesday.

Chris Lange · 11 years ago

Credit Suisse Cuts Columbia Pipeline Partners Rating

Credit Suisse took a look at Columbia Pipeline Partners LP (NYSE: CPPL) and Columbia Pipeline Group, Inc. (NYSE: CPGX) in its most recent report and the outlook is somewhat mixed. With continued weakness in…

Chris Lange · 11 years ago

Globalstar Takes Flight With New Strategic Partnership

Globalstar Inc. (NYSEMKT: GSAT) is leading the bulls late on Tuesday following news a strategic partnership. The company announced a strategic partnership to develop and certify satellite-based internet and voice communications products for the…

Chris Lange · 11 years ago

Westlake Chemical Whiffs on Earnings

Westlake Chemical released disappointing fourth-quarter earnings report before the markets opened Tuesday morning.

Chris Lange · 11 years ago

Chegg Stumbles Over Guidance

Chegg reported mixed fourth-quarter financial results after the markets closed on Monday.

Chris Lange · 11 years ago

PTC Therapeutics Craters on FDA Letter

PTC Therapeutics said that it has received a Refuse to File letter from the FDA regarding its New Drug Application for Translarna (ataluren).

Chris Lange · 11 years ago